WHY IS SMALL CELL CARCINOMA IS SO DEADLY & SMALL CELL CARCINOMA SURVIVAL RATE

 

why is small cell carcinoma is so deadly:

Small cell lung cancer, also known as small cell carcinoma, is a type of lung cancer that is characterized by the small size of the cancer cells. It is an aggressive and fast-growing cancer that typically starts in the bronchi, the larger airways of the lungs.

One of the reasons why small cell lung cancer is so deadly is because it is often found at an advanced stage. The cancer cells can grow and spread quickly, and by the time the cancer is diagnosed, it has often already spread to other parts of the body such as the brain, bones, liver, or adrenal glands. This makes it difficult to treat and results in a poor prognosis.

Another reason why small cell lung cancer is so deadly is because it is often resistant to treatment. The small cell lung cancer cells are able to evade the immune system and traditional treatments such as surgery, radiation therapy, and chemotherapy may not be effective.

Additionally, small cell lung cancer is closely associated with smoking, and the majority of cases occur in current or former smokers. The carcinogens present in tobacco smoke damage the DNA in the cells of the lungs, leading to mutations that can cause cancer.

Furthermore, small cell lung cancer is a neuroendocrine tumor which is characterized by the presence of small, round cells that have a high nuclear-to-cytoplasmic ratio and hyperchromatic nuclei. It is also characterized by a high mitotic index and the presence of neurosecretory granules in the cytoplasm. These features make small cell lung cancer cells particularly resistant to chemotherapy and radiation therapy.

In summary, small cell lung cancer is so deadly because it is often found at an advanced stage, it is often resistant to treatment, it is closely associated with smoking, and it is a neuroendocrine tumor which makes it particularly resistant to chemotherapy and radiation therapy. Additionally, the cancer cells can grow and spread quickly, and by the time the cancer is diagnosed, it has often already spread to other parts of the body.

small cell carcinoma survival rate:

Small cell lung cancer, also known as small cell carcinoma, is a type of lung cancer that is characterized by the small size of the cancer cells. It is an aggressive and fast-growing cancer that typically starts in the bronchi, the larger airways of the lungs.

The survival rate for small cell lung cancer is generally poor. The five-year survival rate for small cell lung cancer is typically around 5-10%. The majority of patients are diagnosed at an advanced stage and the average survival time is around 12-18 months.

It's worth noting that the survival rate can vary depending on the stage of the cancer at the time of diagnosis. For example, the five-year survival rate for stage 1 small cell lung cancer is around 30-40%, while the five-year survival rate for stage 4 small cell lung cancer is less than 5%. Additionally, the overall health of the patient, their response to treatment, and the specific characteristics of their tumor can also affect the survival rate.

Ongoing research and clinical trials are ongoing to find new and effective treatments for small cell lung cancer, and new treatments such as immunotherapy are showing promise for improving outcomes for patients with small cell lung cancer.

In summary, the survival rate for small cell lung cancer is generally poor, with the five-year survival rate typically around 5-10%. The majority of patients are diagnosed at an advanced stage and the average survival time is around 12-18 months. The survival rate can vary depending on the stage of the cancer at the time of diagnosis, the overall health of the patient, their response to treatment, and the specific characteristics of their tumor. Ongoing research and clinical trials are ongoing to find new and effective treatments for small cell lung cancer, and new treatments such as immunotherapy are showing promise for improving outcomes for patients with small cell lung cancer.